Testing a new weight management injection for drug interactions
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new injectable medication for weight management in people with overweight or obesity. It investigates how the drug interacts with other medications and checks its safety. Participation requires a 6-month commitment with regular study visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Between 18 and 45 years old
- BMI between 24 and 35
- Body weight at least 50 kg
- Willing to use contraception and avoid conception for 6 months after the study
- No significant medical conditions or allergies to similar drugs
- No use of certain medications or supplements within 2 weeks before the study
- No recent vaccination or participation in another clinical trial within 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This early-stage study tests a new injectable medication (UBT38006) in healthy adult men to understand how safe it is and how the body processes it. Researchers want to make sure the injection doesn't cause serious side effects and works as expected.
This study tests an experimental injection called UBT37034 to see if it is safe and how the body handles it. It is for people who are overweight but otherwise healthy. By joining, you could help find new ways to help with weight control—and you'll receive close monitoring and care.
This study tests an investigational injection called UBT251 to help people who are overweight or obese lose weight. It may also improve related health issues like high blood pressure or fatty liver. The trial lasts for a period and includes regular check-ins with the study team.
This trial tests a new injected drug (UBT251) for people with type 2 diabetes who haven't been able to control their blood sugar with diet and exercise alone. It aims to see if the drug can help lower blood sugar levels safely.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
Hear when a new Pharmacokinetics and Pharmacodynamics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.